COVAX | VSIAX | COVAX / VSIAX | |
Total Expense Ratio | 1.21 | 0.07 | 1,729% |
Annual Report Gross Expense Ratio | 1.36 | 0.07 | 1,943% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | -11.279 | -4.304 | 262% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 781M | 54B | 1% |
Annual Yield % from dividends | 1.67 | 2.23 | 75% |
Returns for 1 year | -24.26 | 3.83 | -634% |
Returns for 3 years | -20.79 | 26.16 | -79% |
Returns for 5 years | 9.42 | 80.63 | 12% |
Returns for 10 years | -30.25 | 80.44 | -38% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NPFD | 18.92 | -0.06 | -0.33% |
Nuveen Variable Rate Preferred & Income Fund | |||
BCAT | 14.74 | -0.13 | -0.89% |
BlackRock Capital Allocation Term Trust | |||
JGYIX | 12.71 | -0.13 | -1.01% |
JHancock Global Shareholder Yield I | |||
JHJIX | 23.11 | -0.34 | -1.45% |
JHancock ESG Large Cap Core I | |||
MKSPX | 28.53 | -0.46 | -1.59% |
BlackRock Advantage SMID Cap K |